BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 11927473)

  • 1. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
    Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement.
    Larijani GE; Gratz I; Afshar M; McDonald PA; Fisher DM
    Pharmacotherapy; 1995; 15(1):36-41. PubMed ID: 7739943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics.
    van den Broek L; Wierda JM; Smeulers NJ; van Santen GJ; Leclercq MG; Hennis PJ
    J Clin Anesth; 1994; 6(4):288-96. PubMed ID: 7946364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of rocuronium with edrophonium during propofol versus sevoflurane anesthesia.
    Zhou TJ; Chiu JW; White PF; Forestner JE; Murphy MT
    Acta Anaesthesiol Scand; 2001 Feb; 45(2):246-9. PubMed ID: 11167172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements.
    Stout RG; Gan TJ; Glass PS; Silverman DG; Brull SJ
    Acta Anaesthesiol Belg; 2006; 57(4):349-53. PubMed ID: 17236635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anaesthesia.
    Hofmockel R; Benad G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():69-72. PubMed ID: 8557010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency and time course of mivacurium block during sevoflurane, isoflurane and intravenous anesthesia.
    Lowry DW; Mirakhur RK; Carroll MT; McCarthy GJ; Hughes DA; O'Hare RA
    Can J Anaesth; 1999 Jan; 46(1):29-33. PubMed ID: 10078399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time.
    Motamed C; Donati F
    Can J Anaesth; 2002 Nov; 49(9):907-12. PubMed ID: 12419714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of rocuronium during remifentanil-propofol-based anesthesia in children: comparison of intubating conditions.
    Oztekin S; Hepaguşlar H; Kilercik H; Kar AA; Boyaci F; Elar Z
    Paediatr Anaesth; 2004 Aug; 14(8):636-41. PubMed ID: 15283821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the interaction of rocuronium bromide with etomidate, fentanyl, midazolam, propofol, thiopentone, and isoflurane using closed-loop feedback control of infusion of rocuronium.
    Olkkola KT; Tammisto T
    Eur J Anaesthesiol Suppl; 1994; 9():99-100. PubMed ID: 7925218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia.
    Lowry DW; Mirakhur RK; McCarthy GJ; Carroll MT; McCourt KC
    Anesth Analg; 1998 Oct; 87(4):936-40. PubMed ID: 9768798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.